Syntrix Biosystems, Inc.'s Costs Claimed Under the Recovery Act for National Institutes of Health Grant 3R44CA094612-05S2 Were Unallowable
Of the $200,000 of costs that Syntrix Biosystems, Inc., claimed against the Recovery Act grant, the entire amount was unallowable.
Download the complete report
Adobe® Acrobat® is required to read PDF files.
Let's start by choosing a topic
Priority recommendations summarized.
FY 2017 Work Plan
OIG projects planned for 2017.
Significant OIG activities in 6-month increments.